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CHAPTER I 
INTRODUCTION 
Heme iron in oxygenated hemoglobin (Hb) can undergo auioxidation in 
erythrocytes since oxygen is a strong oxidant. Autoxidation converts oxygenated Hb 
(oxyHb) to oxidized (met) Hb (metHb). In a normal red blood cell (RBC), three percent 
of oxyHb is converted to metHb per day (Winterboum, 1985a). Methemoglobin 
reductase converts metHb back to deoxy hemoglobin (deoxyHb) (Chiu et al., 1982). 
Superoxide aniort (02·) (Misra and Fridovich, 1972) and hydrogen peroxide (H20 2) are 
products of Hb oxidation (Winterboum, 1983; Winterboum, 1985b). Therefore in 
oxidized RBC these oxygen radicals initiate chain reactions as lipid peroxidation and 
further protein oxidation (Chiu and Lubin, 1989; Winterboum, 1990a). However, the 
generation of radicals during oxidation of Hb and lipid peroxidation in erythrocytes 
(Halliwell, 1985) does not necessarily lead to cell death, since a normal RBC is equipped 
with an efficient cellular antioxidation system that remove radicals (Chiu et al., 1982). 
Extensive oxidation and heme release within the cytosol or adjacent to the membrane 
may occur in hemolytic disorders or when red blood cells are under oxidative stress 
(Hebbel and Eaton, 1989; Hebbel, 1986). The heme may cause an increase in 
membrane ·rigidity and membrane permeability on erythrocyte membranes. Our 
understanding of Hb toxicity and oxidative stress in erythrocytes under physiological and 
2 
pathophysiological conditions will depend on our knowledge on individual oxidative 
reactions and the exact role of their reaction products generated from Hb oxidation and 
lipid peroxidation in erythrocytes. A better understanding of Hb toxicity in the presence 
of lipid surface will also further efforts to prepare synthetic blood cell substitutes using 
Rb-based oxygen carriers and liposomes (Rudolph, 1988; Bunn, 1993; Tsuchida, 1994; 
Alayash and Cashon, 1995). 
Despite the fact that the Hb toxicity has been studied for over 100 years and 
topics on Hb oxidation and lipid peroxidation in erythrocytes have been well documented 
in literature, our understanding of Hb toxicity is still not definitive. Hb toxicity, other 
than that related to antigenicity, is generally attributed to oxygen radicals and free iron 
generated during Hb oxidation. Although molecular oxygen itself is oxidative with 
respect to superoxide anion radical, hydrogen peroxide, hydroxyl radical and water, its 
oxidative potential is normally held in check by kinetic restrictions (Chiu and Lubin, 
1989). Hydrogen peroxide and superoxide production in the presence of hydroxyl 
radicals occour very slowly in an aqueous solution. However, rapid productions_ of 
hydroxyl radicals may occur in membrane if ferrous salts are present in membrane, 
following a pathway like the Fenton reaction (Fenton, 1894; Haber & Weiss, 1934). 
Previous studies show that in the presence of oxygen radicals and H2O2, destruction of 
heme may occur releasing free iron (scheme I) (Brown and Jones, 1968; Cantoni et al., 
1981). Thus heme iron release and the presence of iron in the aqueous and lipid phases 
are important steps in Hb oxidation in erythrocytes. 
Hydroxyl radicals may interact with organic substrates such as lipid molecules 
3 
and efficiently oxidize lipids, especially those with polyunsaturated fatty acids (Stoock 
A 
N 
I Fe ...._N 
I 
N 
~ 
NH 
Fe 
Scheme 1 
N 
~ 
HN 
and Domandy, 1971), and the implication of lipid peroxidation by hydroxyl radicals has 
been extensive (Chiu and Lubinl., 1989; Sevanian and Hochstein,1985; Chiu et al., 
1982). It is believed that extensive lipid peroxidation in the membrane could lead the 
RBC to premature cell death. However, the intrinsic ability of the hydroxyl radical to 
' 
mediate membrane lipid peroxidation has been questioned. Since hydroxyl radicals are 
extraordinarily reactive, they do not survive for more than a few collisions following 
their formation, and thus their reactions are intrinsically site specific (Chiu et al., 1982). 
It is highly unlikely that these highly reactive intracellular hydroxyl radicals are able to 
migrate to the lipid acyl chain region to initiate lipid peroxidation. The hydroxyl radical 
is more likely to react with substrates near the site of its generation. However, if heme 
or heme iron act as a Fenton reagent in the lipid phase (Kanner and Harel, 1985; Puppo 
and Halliwell, 1988 ; Gutteridge et al., 1994), and catalyze the production of hydroxyl 
radicals in the lipid phase, this may provide a possible explanation for the ability of 
highly reactive hydroxyl radicals to initiate lipid peroxidation (Chiu and Lubinl., 1989). 
4 
It has also been suggested that a Fe+3-dioxygen-Fe+2 complex, and not hydroxyl radical, 
was the oxidant to initiate lipid peroxidation (Minotti and Aust, 1987). In either model, 
the presence of iron in lipid phase is again a critical component for lipid peroxidation. 
However, little information is available on the kinetics of free iron released from Hb and 
its accumulation in lipid phase. 
I used a model Rb-vesicle system with purified Hb in reduced form (oxyHb) and 
uniform size lipid vesicles with no initial lipid peroxidation products (LaBrake and Fung, 
1992) to study the initial phase of Hb oxidation. This system allows us to specify the 
oxidation states of the reactants (Hb and lipid) and reactant concentrations as well as lipid 
hydrophobicity. The system also consists of no exogenous oxidants to complicate 
interpretation of experimental results, since different exogenous oxidants may exhibit 
different Hb oxidation kinetics and products (van den Berg et al., 1992). I also used 
different buffer conditions to study the pH and the ionic strength effects on heme tranfer 
into the lipid phase. Thus this model system provides a well-characterized system for 
following various intermediate oxidation products in Hb oxidation in the presence of lipid 
surface. It is obviously critical to characterize the intermediates under the same 
experimental condition. Yet results of Hb oxidative studies under various conditions, 
including different salt concentrations (Marva and Hebbel, 1994), different pH (Sugawara 
et al., 1993) and different lipid compositions as well as lipid vesicles with different sizes 
(Yang and Huesstis, 1994), were often compared with each other. Sometimes, different 
in vivo phenomenon has been interpreted using results from non-physiological 
conditions (Marva and Hebbel, 1994). Previous studies have shown that lipid surface 
5 
enhances the initial disappearance of oxyHb (LaBrake and Fung, 1992). I have now 
extended the study to include the kinetics of iron accumulation in lipid phase in the Rb-
small unilamellar vesicle (SUV) system. I also characterized different intermediate 
reactions in Rb-lipid systems. 
I also used sickle Hb (HbS) for a comparative study with HbA. It has been 
reported that HbS has abnormal oxidation properties (Hebbel, 1986). I found that 
oxidative reactions in Rb-SUV . mixture depended on buffer conditions. The 
disappearance of oxyHb was slower in buffers with physiological ionic strength and pH 
than in buffers with low ionic strength and low pH, as expected. Under physiological 
buffer conditions, extensive iron accumulation in the lipid phase was observed. 
Surprisingly, iron concentrations in the aqueous phase, after initial increases, decreased 
as a function of time, whereas iron concentrations in the lipid phase continued to 
increase. Eventually all iron ions released from Hb were found in the lipid phase. Little 
difference was observed between HbA and HbS systems. 
2 .1 Materials 
CHAPTER II 
MATERIALS AND METHODS 
An important aspect of these experiments was to have all glassware acid washed 
before use. All the buffers were prepared with HPLC grade water, treated with chelex 
100 (BioRad, Richmond, CA) and filtered through an 0.2 micron filter (Gelman Science 
Ann Arbor, MI) to eliminate trace metal ions and any exogenous oxidants. Bovine 
phosphatidylserine (BPS) was purchased from Avanti Polar Lipids (Albaster, AL). All 
other chemicals were purchased from Sigma (St Louis, MO), Fisher (Pittsburgh, PA) or 
Aldrich (Milwaukee, WI). 
2.2 Buffers 
Phosphate (35 mM) or tris (10 mM) based buffers were used. Variation of ionic 
strength (osmolarity) was achieved by addition of either NaCl or KCl to buffers. Precise 
osmolarity values were measured using a Vapor Pressure 5500 Osmometer (Wercor, 
Logan, UT). The following abbreviations were used to represent different buffer 
systems. We designated phosphate buffers with P and tris buffers with T, followed by 
salt concentration (mM), then by Nor K for NaCl and KCl salt used respectively and 
ended by its pH value. For example, Pl10N7.4 was a phosphate buffer containing 110 
6 
7 
mM NaCl at pH 7.4, and T5K6.5 was a tris buffer containing 5 mM KCl at pH 6.5. 
Pll0N7.4 was used in our earlier studies (La.Brake and Fung, 1992) and was a buffer 
with ionic strength and pH similar to physiological conditions. T5K6.5 was the buffer 
used by others in a study of sickle Hb oxidation in the presence of lipid vesicles (Marva 
and Hebbel, 1994) and was a low salt and low pH buffer. Other buffers used include 
P10N7.4, P10N6.5, P50N6.5, PON6.5, T85K6.5, T20K6.5, T5K6.5 and T5N6.5. 
2.3 Hemolysate Preparation 
Packed RBCs (normal RBC or sickle RBC) were washed using 4 volumes of 35 
mM phosphate and 150 mM NaCl pH 7.4 buffer (PBS). The washing was performed 
by suspending the RBC in the buffer and then centrifuging at 1500 g for 10 min. The 
supernatant and the huffy coat was removed by aspiration. This washing was repeated 
4 times until the supernatant were clear. The washed RBCs were then lysed by addition 
of 2 volumes of cold DI water. A 77% ammonium sulphate solution at pH 7.0 was used 
for the precipitation of membrane proteins in the lysed RBCs. This solution was then 
centrifuged and the supernatant was obtained. The solution was CO gassed and dialyzed 
overnight against 5 mM phosphate pH 7.4 buffer to remove 2,3 -diphosphoglycerate and 
other small molecules. The resulting solution was then CO gassed, concentrated and 
stored at -70 °C (La.Brake and Fung, 1992). 
2.4 Hemoglobin Preparation 
Hb (HbA or HbS) was isolated from stripped hemolysate that was previously 
8 
prepared and was stored at-70 °C. The hemolysate was separated on a DEAE-sephadex 
A-50 (Pharmacia, Piscataway, NJ) column under a pH gradient made from 5 mM tris 
and 150 mM EDTA at pH 8.3 and pH 7.0. HbA was eluted at pH 7.75 and HbS was 
eluted at pH 7.9 (Winterbourn, 1985c; La.Brake and Fung, 1992). The purified 
hemoglobin fractions were CO gassed and dialyzed against 35 mM phosphate and 110 
mM NaCl pH 7.4 buffer. Samples were tested for SOD and catalase activity (Watkins 
et al., 1985). No enzyme activity was found in the hemoglobin samples. The dialyzed 
Hb was frozen drop-wise in liquid N2 and stored at -70°C. 
2.5 Oxyhemoglobin Preparation 
Carbon monoxy Hb (HbACO and HbSCO) was oxygenated for 45 min on ice 
while illuminated by a flood light. The concentration was adjusted to the required 
concentrations using the absorbance at 577 nm and the extinction coefficient of 15.0 
(mM/ hemeY1 cm·1 (Winterbourn, 1985c; La.Brake and Fung, 1992). 
2.6 MetHemoglobin Preparation 
HbA or HbS (160 µM) was treated with potassium ferrithiocyanate in a molar 
ratio of 1 mole heme : 3 moles of potassium ferrithiocyanate. The solution was stirred 
for 10 min and the excess potassium ferrithiocyanate was separated on a Sephadex G25 
(Pharmacia, Piscataway, NJ) column equilibrated with 35 mM phosphate, 110 mM NaCl 
pH 7.4 buffer (Perutz, 1972). This column separation allowed us to remove the excess 
potassium ferrothiocyanate from metHb. The metHb fractions were pooled and the 
9 
concentration was determined by using the absorbance at 405 nm and its extinction 
coefficient of 149 mM-1 (Perutz, 1972). 
2. 7 SUV Preparation 
The BPS in CHC13 was evaporated under N2 on a rotary evaporator to remove the 
CHC13 and to obtain a thin lipid film. The film was solubilized in N2 gassed phosphate 
buffer or tris buffers to prepare multi lamellar vesicles (MLVs). SUVs were prepared 
by sonication (LaBrake and Fung, 1992) using a VC SOT Vibra Cell™ sonicator (Sonics 
& Materials Inc. Danbury, CT) and a 2 mm probe. A volume of 1 ml, of ML Vs in 
phosphate buffers was sonicated for 4 min at power 40 and/or 1 ml of ML Vs in tris 
buffers was sonicated for 2 min at power 20. The clear solution obtained after sonication 
was centrifuged at 38,000 g for 20 min to pellet large lipid vesicles and particulates 
(LaBrake and Fung, 1992). 
2.8 Conjugated Diene Assay 
The ~onjugated diene assays (A233/ A215 index) were performed on the lipid samples 
to determine lipid peroxidation (Kim and LaBella, 1987). A sample of 10 µI of the lipid 
vesicles were mixed with 1 ml of ethanol and the absorbance at 233 nm and 215 nm were 
measured. The wave lengths were calibrated by using 10µ1 phosphatidylcholine in 1 ml 
of absolute ethanol. The blank phosphatidylcholine solution was made the same 
concentration as the sample to be assayed in absolute ethanol. (Kim and LaBella, 1987). 
Samples with an index of 0.08 are considered to be low lipid peroxidation and with 0.66 
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are considered to be high index of lipid peroxidation (Szebeni and Toth, 1986). The 
samples having an index above 0.2 were rejected (Szebeni and Toth, 1986; LaBrak:e and 
Fung, 1992). 
2. 9 Phospholipid Assay 
The lipid concentrations of SUV samples were determined by the method of 
Stewart (1980). A sample of 25 µl of the BPS SUV was extracted with a mixture of 1.5 
ml of water, 2 ml of CHC13 and 2 ml of MeOH. The CHC13 layer was evaporated to 
dryness under vacuum or N2• It was then redissolved in 2 ml of CHC13 and 2 ml of 10 
N ammonium ferrothiocyanate solution was added to obtaine a red complex. The 
mixture was vortexed for 2 min. The CHC13 layer was separated, and the absorbance 
at 452 nm was obtained. The concentration of the lipid was calculated using the E of 1.9 
for a 0.5 mg I ml PS solution (Stewart, 1980). 
The average effective diameter of SUV s determined by quasi elastic light 
scattering (QELS) particle size analyzer(Brookhaven Instruments, New Haven, CT) was 
87.5 ± 5 nm (n = 3) for SUVs made in PllON 7.4 buffer and 88 6.8 nm (n = 3) 
for SUVs made in T5K 6.5 buffer. The effective diameters of SUVs obtained from the 
QELS are generally larger than what were obtained by electron microscopy (EM) (Mayer 
et al., 1986). An effective diameter of - 90 nm corresponds to a 10-30 nm diameter 
measured by EM (LaBrake and Fung, 1992). Thus the SUVs used in this study were 
similar to those used in our earlier studies of Hb oxidation (LaBrake and Fung, 1992). 
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2.10 Hemoglobin-SUV Mixtures 
Hb and SUVs solutions were incubated at 37°C in phosphate buffers or at 28°C 
in tris buffers of different ionic strength and were mixed to give a sample with a specific 
phospholipid/Hb molar ratio. For samples with phospholipid to Hb molar ratio of 800, 
240 µL of Hb (17.7 µM) and 1.0 ml of SUVs (3.4 mM BPS) were mixed to give a final 
concentration of 3.4 µM for Hb and 2. 7 mM for BPS. For other phospholipid/Hb ratios 
(360, 200 or 45), sample volume and Hb concentration were held constant, BPS 
concentrations were varied. The phospholipid to Hb ratio of 45 was the same as that 
used by Marva and Hebbel (1994). 
2.11 Disappearance of OxyHemoglobin 
UV-Vis absorption intensities from 500 nm to 700 nm were monitored for I h. 
The oxidation of Hb was determined by using the four component (oxyHb, metHb, 
hemichrome and choleglobin) analysis method (Labrake and Fung, 1992). The oxyHb, 
metHb, hemichrome and choleglobin concentrations were determined by matrix equations 
assay the absorbance at 577, 630, 560, and 700 nm, (Labrake and Fung, 1992; 
Winterbourn, 1985c). The pseudo first order rate constant (k) for the disappearance of 
oxyHb was obtained by fitting the logarithmic values of oxyHb concentration ([oxyHb]t 
(%)) versus time (t) to an linear equation of In [oxyHb]t = kt. 
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2.12 Disappearance of Heme/Porphyrin 
Fluorescence signals of porphyrin were used to detect heme concentration 
(Schwartz et al., 1983). An oxalic acid/FeSO4 solution was used to dissociate FeH /Fe2+ 
from porphyrin in free heme or heme moiety in Hb. Five microliter of Hb-SUV 
mixtures were mixed well with 3 µl of Triton-X-100 and added to 1 ml of FeSO4'oxalic 
acid solution (2.5 g of FeSO4 and 30.0 g of oxalic acid in 100 ml of DI water) (Schwartz 
et al., 1983). The sample was heated at l00°C for 0.5 hand then cooled for 15 min at 
room temperature. The fluorescence emission at 601 nm, with excitation at 405 nm, was 
measured. Porphyrin concentration in the mixture was determined by using a calibration 
curve made with Hb (concentration range of 0.1 µM to 30 µM) as the standard. The 
porphyrin concentration was monitored as a function of time (t) in the Hb-SUV mixtures. 
The decrease in the fluorescence signals was used as an indication of porphyrin 
disappearance. A semi-logarithmic plot of [porphyrin] (%) versus time (t) was obtained, 
and the slope from a linear regression analysis provided the first order rate constant (k) 
for porphyrin disappearance in the presence of lipid vesicles. 
2.13 Heme Partitioning into the Aqueous Phase 
MetHb was used as the heme donor and apomyoglobin (apoMb) as the acceptor 
for free heme in solution (Paul et al., 1991). MetHb concentration was adjusted to 3.4 
µM per heme and the apoMb concentration to 17 µM to give a 5 molar excess of 
apomyoglobin in the reaction mixture. Changes in absorbance at 409 nm were monitored 
as a function of time at 25°C instead of 37°C, since absorbance changes were too fast 
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to follow at 37°C. The difference in absorbance values at 409 nm between metHb (3.4 
µM) and myoglobin (heme-containing myoglobin) (3.4 µM) in specific buffer was used 
to represent complete heme extracted in that buffer. 
2.14 Heme Transfer from Hemoglobin to SUVs 
SUVs were separated from Hb in Hb-SUV mixtures by size exclusion column 
chromatography. Samples were loaded immediately after mixing ( < 5 min) to a FPLC 
Superose 12 (Pharmacia) column, and the elution time was about 15-20 min for SUV 
fractions and about 60 min for Hb. Porphyrin and lipid concentrations were determined 
on pooled SUV fractions. A hundred microliter sample from the pooled SUV fractions 
in 3 µL Triton X-100 was used for porphyrin assays. Fractions of heme transferred from 
Hb to SUV s were calculated as [porphyrin per mg lipid in SUV pooled 
fractions]/[porphyrin per mg lipid in Hb-SUV mixture] (%). Since the heme transfer 
process was faster than our separation process (we estimated it to be about 10 min or less 
on our Superose column) for systems in T5K6.5 buffer, we were not able to determine 
kinetic properties of heme transfer to SUVs. Therefore only the extent of heme transfer 
to lipid phase was obtained. 
2.15 Free Iron Concentration 
Free iron concentration in samples was determined with ferrozine/neocuprion 
reagent (75 mg ferrozine, 75 mg of neocproine hydrate and one drop of cone. HCl in 
25.00 ml water) (Carter, 1971). Equal volumes (125µL) of sample and ascorbic acid 
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(0.02 % in 0.2 N HCI) were mixed and left at room temperature for 5 min. 
Trichloroacetic acid (10 % ) solution (125 µL) was then added, mixed and centrifuged at 
16,000 g for 10 min to obtained a clear supernatant. Ferrozine/neocuprion reagent (25 
µL) and 10 % sodium acetate (100 µL) were added to the supernatant (250 µL). The 
concentration of free iron was determined by monitoring absorbance at 562 nm for the 
formation of magenta colored complex of FeH with ferrozine. A calibration curve was 
obtained using Fe(NH4) 2SO4 • 6H2O (104 µM to 30 µM). 
Triton X-100 was added to the sample prior to the addition of assay reagents to 
determine total (lipid phase plus aqueous phase) Fe ion concentrations. Aqueous phase 
iron concentrations were assayed in the absence of Triton X-100. Iron concentrations 
in the lipid phase were obtained by subtraction. Iron concentrations were monitored as 
a function of time in Hb-SUV mixtures. 
2.16 Cross-Linked Hemoglobin in the Hb-SUV mixture 
Hb-SUV mixture was incubated at 37 °C. Samples were obtained every hour and 
loaded to a 16 % SDS PAGE stained with Coomassie Blue. The bands on the gel were 
scanned using the Logitech Scan-Man II (Logitech Inc., Fremont, CA), and the band 
intensities as a function of time in each lane were analyzed with Sigma Gel soft ware 
(Iandel, San Rafel, CA). The experiments was performed in Pll0N 7.4 buffer at 37 °C, 
with a phospholipid/Hb molar ratio of 800, and in T5K 6.5 buffer at 28 °C, with a 
phospholipid/Hb molar ratio of 360. 
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2.17 Appearance of Malondialdehyde (MDA) 
Thiobarbituric acid (TBA) solution was prepared by mixing TBA (0.375 mg) and 
trichloroacetic acid (TCA) (10 g) in 100 ml of 0.2 N HCl solution. A sample of 50 µl 
of the Hb-SUV mixture was added into 500 µl of TBA solution. The sample was boiled 
for 30 min, cooled at room temperature for 15 min and centrifuged at 16,000 g for 10 
min. The TBA forms a complex with the MDA giving rise to a pink colored compound. 
The absorbance of the TBA-MDA complex (thiobarbituric acid reactive substances, 
TBARS) formed was determined at 532 nm. The concentration of TBARS was 
determined by using a calibration curve of MDA within a concentration range of 0.10 
µM to 10.00 µM (Buege and Aust, 1978). The experiments were performed in Pll0N 
7.4 buffer at 37 °C and at a phospholipid/Hb molar ratio of 800. 
2.18 Oxidative Products in the Hemoglobin-SUV Reaction Mixture 
Hb-SUV mixture was incubated for 0, 2, and 6 h, followed by separation on a 
Sepharose 4B-CL (Pharmacia, Piskataway, NJ) column (42 x 1.5 cm) equilibrated with 
the experimental buffer (13.5 ml/min). The molecular weights of the separated 
components were determined using a calibration curve prepared with ribonuclease A 
(13.7 kDa), carbonic anhydrase (23 kDa), ovalbumin (43 kDa), bovine serum albumin 
(67 kDa), aldolase (158 kDa) and ferritin (440 kDa) as the molecular weight standards. 
The experiments were performed in Pl l0N 7.4 buffer at 37 °C and at a phospholipid/Hb 
molar ratio of 800 and in T5K 6.5 buffer at 28 °C and at a phospholipid/Hb molar ratio 
of 3ti0. 
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The separated peaks from HbA-SUV mixture at PL/Hb molar ratio of 800 were 
tested for carbonyl functions using UV /Vis spectra. 
2.19 Lipid Bound to the Hemoglobin 
The pooled fractions separated on a Sepharose 4B-CL column as described above 
were extracted with CHCl3'MeOH (1:1 v/v) mixture. The CHC13 phase was separated 
and evaporated to dryness. The dried sample was redissolved in 2.0 ml CHC13 and the 
lipid content was determined by the lipid assay (Stewart, 1980). Alternatively the dried 
sample was redissolved in 200 µ.l CHC13 and loaded on to a high performance thin layer 
chromatogram (HPTLC). The HPTLC plate was first activated with a CHCl3'MeOH (1: 1 
v/v) mixture and the plate was dried for 5 hat 120 °C. The plate was then cooled for 
1 h in a CaCO3 desiccator. A 20 µl sample was loaded to the plate and eluted with 
CHCl3' MeOH I NH4OH (60 : 20 : 4 v/v) to half the length of the plate for high polar 
components. After air drying the plate was eluted with hexane/diethyl ether/ HOAc (80 
: 20 : 0.5 v/v) for the full length of the plate. The plate was visualized by spraying 
the plate with 10% CuSO4 in 10 % phosphoric acid and then charring the plate at 160 
°C for 10 min. The charred spots of the sample were compared with those from BPS 
(Avanti Polar Lipids) and stearic acid (Sigma Chemicals). The experiments were 
performed in Pl ION 7.4 buffer at 37 °C and at a phospholipid/Hb molar ratio of 800 and 
in T5K 6.5 buffer at 28 °C and at a phospholipid/Hb molar ratio of 360. 
CHAPTER III 
RESULTS 
Previous studies have shown that the oxidation kinetics of oxyHb in Hb-SUV 
mixtures depends linearly on phospholipid to Hb molar ratio (LaBrake and Fung, 1992). 
The higher the molar ratio, the faster the reactions. In this study, I found that oxidation 
kinetics depended on buffer conditions. I used smaller phospholipid to Hb molar ratio 
values in samples with buffer conditions that provided faster kinetics and larger molar 
ratios in samples with buffer conditions that provided slower kinetics. A molar ratio of 
800 was used for systems in P110N7.4 buffer and molar ratios of 360, 200 and 45 for 
systems in T5K6.5 buffer. These adjustments in molar ratios positioned oxidative 
reactions in Hb-SUV mixtures under different buffer conditions to similar time frame 
(minutes to hours) and thus provided results under different conditions with similar 
reliability. If the molar ratio was kept the same for systems with different buffer 
conditions, the oxidative reactions would span vastly different time frames (e.g. msec or 
days). 
3.1 Oxidative Reactions Under Physiological pH and Ionic Strength Conditions 
(PllON 7.4) 
3.1.1 Disappearance of OxyHb 
Disappearance of Hb was determined by analyzing the UV-Vis absorption spectra. 
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Figure L 
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Spectral changes from 500 - 700 nm ofHbO2 + BPS SUVs in Pll0N 7.4 
buffer as a function of time at lipid to Hb molar ratio of 800 and 37 °c. 
The time interval between each spectrum was 6 min, with the bottom 
spectrum taken immediately after mixing HbO2 and SUVs and the top 
spectrum taken at 45 min after mixing. Characteristic absorption peaks 
for oxyHb at 577 nm and 565 nm was observed at t = 0, and a 
prominent peak at 630 nm were observed at t = 45 min. A. HbAOi 
+ BPS SUVS and B. HbSO2 + BPS SUVs 
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Figure 2. 
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The semi-logarithmic plot of oxyHb concentration(%) versus time (h) for 
the disappearance of Hb in the presence of BPS SUV s in Pl 1 ON 7 .4 buffer 
at lipid to Hb molar ratio of 800 and 37 °c. The value at each time point 
was the mean value of 2 experimental runs. o HbAO2 + BPS SUVS and 
■ HbSO2 + BPS SUVS 
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A typical set of spectra obtained on HbA-SUV sample and HbS-SUV sample in Pl lON 
7.4 buffer as a function of time (Fig. IA & B) shows a decrease in the two characteristic 
peaks for oxyHb at 577 and 565 nm, due to the disappearance of oxyHb, and an increase 
in absorbance at 630 nm, due to the formation of metHb as well as a slight increase in 
absorbance at 700 nm which was attributed to the formation of choleglobin and fusion 
of lipid vesicles (La.Brake and Fung, 1992). A four component (oxyHb, metHb, 
hemichrome and choleglobin) analysis (LaBrake and Fung, 1992) of these spectra 
allowed us to determine oxyHb concentrations as a function of time in our Hb-SUV 
mixture. The semi-logarithmic plot of oxyHb concentration (%) versus time revealed a 
linear relationship during the initial phase (up to about 0.5 h) for both HbA and HbS 
SUV oxidation reaction mixtures (Fig. 2). Linear fitting of the first 11 data points (0 -
0.5 h) provided a pseudo first order rate constant for the initial disappearance of oxyHb 
in the presence of SUVs. The mean rate constant of 2. 77 + 0.08 h-1 (n = 3) was 
obtained for HbA-SUV mixture. The time for the disappearance of 50 % of the 
maximum value (tuJ of oxyHb concentration was 0.25 h. The reported rate constant 
of the HbA oxidation under similar conditions was 3.20 ± 0.52 h·1 (La.Brake and Fung, 
1992). The mean rate constant of HbS oxidation was 2.70 + 0.09 h·1 (n = 3) (Fig. 2) 
and the t112 for the disappearance of oxyHbS was 0.25 h . These values were very 
similar to those of HbA system in PI ION 7.4 buffer. 
3.1.2 Oxidative Products in Hb-SUV Mixtures in Pl10N7.4 
Upon mixing (t - 5 min) of oxyHbA and SUVs in Pll0N7.4 with aphospholipid 
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ratio of 800, two fractions were separated by size exclusion column (Sepharose 4B-CL) 
(Fig. 3). The first fraction eluted at void volume of 23.6 ml (elution time of 1.75 h) and 
was identified as SUVs. This peak consisted of 2.4 - 2.6 mg of phospholipid, as 
determined by phospholipid assays, which corresponded to about 80 - 85 % of the total 
amount of BPS loaded to the column. The second fraction eluted at 65. 7 ml (elution 
time of 4.8 h), corresponding to a molecular mass of 64 ± 0.2 kDa (n = 2), and was 
assumed to contain mostly HbA (Fig. 3 a). Small amounts ofphospholipid (0.11 ± 0.02 
mg or about 4 % of total BPS) was detected by phospholipid assays. As shown earlier, 
about 36 % of HbA molecules already exhibited inter-chain cross-linking, but remained 
as tetramers under these conditions. 
After 2 h incubation, the lipid vesicle peak (at the void volume of 23.6 ml) 
became more intense, probably due to vesicle fusion induced by Hb molecules to give 
extensive light scattering at 280 nm (LaBrake and Fung, 1992). This fraction consisted 
about 80 - 85 % of the total amount of BPS loaded, as determined by phospholipid 
assays. No fraction was collected at the 65.7 ml position. However, a fraction at 63.7 
ml (elution time of 4. 7 h), corresponding to a molecular mass of 94 kDa, and a fraction 
at 81.6 ml (elution time of 6.0 h), corresponding to a molecular mass of 2 kDa, were 
collected (Fig. 3 b). Globin cross-linking studies discussed earlier showed about 62 % 
of Hb as monomers, 26 % as dimers and 12 % as trimers, and these values were very 
similar to those observed at t - 5 min. The shift in molecular mass from 64 kDa to 94 
kDa was thus assumed due to an increased amount of SUV /BPS associated with Hb 
molecules. The fraction with low molecular weights (2 kDa) was not analyzed but was 
Figure 3. 
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The elution profiles of the separation of the HbA-SUV mixture on the 
sepharose 4B-Cl gel filtration column. The HbAO2+ BPS SUVs in Pl ION 
7.4 buffer at a lipid to Hb molar ratio of 800 and at 37 °C were incubated 
for 0, 2 and 6 h and was separated on a sepharose 4B-Cl gel filtration 
column. 
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assumed to be similar to the 79. 7 ml fraction at t = 6 h, as described in detail below. 
After the Hb-SUV mixture was incubated for 6 h, other than the lipid peak, which 
still consisted about 80 % phospholipid, a fraction at 61.2 ml (4.5 h), corresponding to 
a molecular mass of 184 + 11 k:Da, and a fraction at 79. 7 ml (4. 7 h), corresponding to 
a molecular mass of 3 ± 0.5 k:Da (n = 2), were detected {Fig. 3c). The fraction at 61.2 
ml (184 k:Da) exhibited no absorption peaks characteristic of the heme moiety and was 
assumed to be mostly globin aggregates or choleglobin (gel electrophoresis data showed 
:ii? 75 % globin cross-linking). Pacifici and coworkers, in their studies of Hb oxidation 
by hydrogen peroxide, observed a peak on a Sepharose 4B column that corresponded to 
120 - 180 k:Da (Pacifici et al., 1993). This fraction also consisted of small amounts of 
phospholipid (0.26 ± 0.02 mg, n = 2 phospholipid or about 8 % total, as detected by 
phospholipid assay). HPTLC data also indicated the presence of BPS as well as fatty 
acids and aldehydes {Fig. 6, Lanes 2). The fraction at 79. 7 ml (3 k:Da) exhibited a sharp 
absorbance at 265 nm that corresponded to conjugated carbonyl groups (Fig. 5). This 
fraction also exhibited a trace level of BPS and fatty acids and other aldehydes, as 
detected by HPTLC (Fig. 6, lane 5). Only about 1.5 % of total BPS (0.05 + 0.01 mg; 
n = 2) was detected in this fraction. Thus this fraction probably consisted of low 
molecular weight lipid peroxidation products. 
I observed similar changes when HbS-SUV mixture that was separated on the 
sepharose 4B-Cl column( Fig. 4). Initially when the Hb-SUV mixture was separated the 
Hb fraction with a molecular weight of 64 k:Da and the lipid fraction eluted off with the 
void volume {Fig. 4 a) . When the HbS-SUV mixture was incubated for 6 h the 
Figure 4. 
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The elution profiles of the separation of the HbS-SUV mixture on the 
sepharose 4B-Cl gel filtration column. The HbSO2+ BPS SUVs in Pl l0N 
7.4 buffer at 37 °C with a lipid to Hb molar ratio of 800 andwere 
incubated for 0, 2 and 6 h and was separated on a sepharose 4 B-Cl gel 
filtration column. 
Elution Profiles of HbS-SUV Mixture Separated on a Sepharose 4B-Cl Column, in 
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The UV /Vis spectrum of 3 kDa fraction obtained from the column 
separation of HbA-SUV mixture at 37 °c with phospholipid to Hb molar 
ratio of 800. 
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The high performance thin layer chromatogram of the CHC13 extract of 
the Hb fractions and the byproduct fractions separated from the size 
exclusion chromatography at t = 6 h (see Fig. 2). The TLC was eluted 
with CHCl3'MeOH/NH3OH (60:20:4) up to 50 % of the plate length and 
then the plate was eluted with hexane/diethyl ether/HOAc (80:20:0.5) up 
to 100 % of the plate length. The plate was visualized using 10 % CuSO4 
in 10 % phosphoric acid and charring at 160 °C for 10 min. 
Lane 1- BPS (Avanti Polar Lipids) 
Lane 2- CHC13 extract of the 61.2 ml (184 kDa) fraction of HbA-SUVs 
mixture 
Lane 3- CHC13 extract of the 61.8 ml (190 kDa) fraction of HbS-SUVs 
mixture 
Lane 4- Stearic acid 
Lane 5- CHC13 extractt of the 79. 7 ml (3 kDa) fraction of HbA-SUVs 
mixture 
Lane 6- CHCI3 extract of the 79. 7 ml (3 kD) fraction of HbS-SUVs 
mixture 
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eluted fractions we observed two new peaks appearing with molecular weights of 190 
kDa and 3 kDa ( Fig. 4 c) similar to HbA-SUV mixture. 
3.1.3 Globin Cross-Linking 
The reaction mixture was also characterized using SDS PAGE. The Hb-SUV (t 
- 5 min) exhibited bands at 15 kDa (64 % of total), 30 kDa (24 % ) and a faint band at 
45 kDa (12 %) of Hb (Fig. 7 A & B) for both HbA and HbS SUV mixture. Since a 
native Hb gave rise to only a band at 15 kDa, under similar gel conditions the 15 kDa 
band in Hb-SUV samples corresponded to those Hb molecules that were not cross-linked 
and the higher molecular weight bands were due to covalently cross-linked a and /3 
chains (cross-linked a/3 at 30 kDa, dimers and a/3a or a/3/3 at 45 kDa, trimers) (Fig. 8). 
Thus at t - 5 min about 36 percent of globin were already cross-linked. At 2 h of 
incubation SDS PAGE data showed 62 % of Hb as monomers 26 % as dimers and 12 
% as trimers chains. These values were similar to those obtained immediately after 
mixing (t - 5 min). 
I observed an increase in globin cross-linking in the Hb-SUV oxidation sample 
with prolonged incubation with 43 ± 12 % at 3 h, 64 + 6 % at 4 h and 75 ± 5 % _at 
5 h (n = 2) (Fig. 8). Similarly I observed the cross-linking of HbS in the presence of 
SUV and observed 30.0 %, 27 %, 41 %, 48 %, 66 % and 70 % at - 5 min, 1 h, 2 h, 3 
h, 4 h, and 5 h respectively (Fig. 8). The samples showed the appearance of bands with 
a higher than 45 kDa. These results agreed with previous findings of Hb oxidation in 
the presence of H20 2 (Pacifici et al., 1993). They observed the appearance of the 32 
Figure 7. 
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The 16 % SDS PAGE performed on the Rb-SUV mixture in PllON 7.4 
buffer at lipid to Hb molar of 800 and 37 °C, at different incubation times. 
The 50 µl of the sample was loaded to the gel. A. HbA-SUV mixture, B. 
HbS-SUV mixture 
SDS PAGE ofHb-SUV Mixture in PllON 7.4 Buffer 
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Figure 8. 
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The % of cross-linked Hb in the Hb-SUV mixture in Pl lON 7.4 buffer at 
lipid of Hb molar of 800 and 37 °Casa function of incubation time (h). 
The cross-linking was monitored by performing a 16 % SOS PAGE. The 
% intensity of each band was obtained by using Logitech Scan Man for 
scanning and Sigma Gel analyzing software for the gel % analysis. 
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kDa, and 48 kDa bands on a SDS PAGE. The t112 values for the cross-linking of Hb 
was estimated to be 3.5 h for both HbA and HbS in SUVs. The cross- linked globin was 
also identified as choleglobin, a species that is not well identified in the literature, but 
is generally considered as denatured globin. 
3.1.4 Disappearance of Heme/Porphyrin 
I observed the fluorescence intensity of the porphyrin in Hb-SUV samples 
decreasing with time (Fig. 9). The first order rate constant for the initial porphyrin 
(heme) disappearance was 0. 76 + 0.12 h·1 (n = 3) for HbA-SUV mixture and 0. 79 ± 
0.11 h·1 (n = 3) for HbS-SUV mixture followed by a second first order rate constant 
of 0.43 ± 0.23 h·1 (n = 3) for HbA and 0.50 ± 0.35 h·1 for HbS. At 0.5 h 63 % of 
heme was left in the oxidation reaction mixture, and at 1.0 h it decreased to 45 % for 
both HbA and HbS - SUV mixtures. The t112 value for the destruction of heme was 0. 75 
h for both HbA and HbS. The results obtained for HbS-SUV mixtures were very similar 
to those of HbA-SUV mixture. 
3.1.5 Heme Transfer into the Lipid Phase (SUVs) 
I observed only about 1 % heme transferred to the lipid phase upon mixing oxyHb 
with SUVs in Pll0N :7.4 buffer for both HbA (1.10 ± 0.02 % , n =2) and HbS (1.15± 
0.07 % , n =2). 
Figure 9. 
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The semi-logarithmic plot of heme concentration ( % ) versus time (h) in 
Hb-BPS SUV mixture in Pl lON 7.4 buffer at lipid to Hb molar ratio of 
800 and 37 °C. The heme concentration was determined by fluorescence 
spectroscopy as described in the Methods section. The fluorescence 
emission of the solution was obtained at 601 nm with the excitation at 405 
nm. The values presented were mean values of 3 experimental runs. ■ 
HbA02 + BPS SUVs and O HbS02 + BPS SUVs 
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3.1.6 Appearance of Free Iron 
The free iron concentration in the Hb-SUV mixture increased as a function of 
incubation time. However the semi-logarithmic plot of free iron concentrations in both 
aqueous phase and lipid phase as a function of time could not be fitted with a linear 
equation (Fig. 10). Therefore I was not able to describe the iron released from Hb with 
a first order rate constant. The mean value of the free iron concentration was 27.4 ± 
4.9 % (n = 3 ) for HbA- SUV mixture and 27.1 ± 8.0 for HbS-SUV mixture at 0.5 
h, and 100 %at 10 h (Fig. 10). for both HbA and HbS-SUV mixtures. All the iron in 
Hb molecules was released after 10 h incubation with SUV s. The free iron 
concentrations in HbS-SUV mixture were similar to those in HbA-SUV mixture. The 
t112 values for the total iron released from HbA and HbS in the presence of SUV s were 
about 1.3 h. 
The concentrations of free iron in the aqueous phase increased initially and 
reached a maximum value of 33.8 + 0.0 % (n= 2) at 2.5 h for HbA -SUV mixture 
(Fig. 4), and 37.1 ± 0.0 % (n= 2) for HbS-SUV mixture. The concentrations in the 
aqueous phase decreased after 2.5 h in HbA-SUV mixture and HbS-SUV mixture. At 
10 h the mean concentration decreased to 23.1 + 4.8 % (n= 2) for HbA-SUV mixture 
and 16.4 ± 1.0 % (n= 2) for HbS-SUV mixtures. The t112 value was about 0.8 h for 
both HbA and HbS. 
The free iron concentrations in the lipid phase continued to increase with time for 
both HbA-SUV and HbS-SUV mixtures. At t = 2.5 h, 23.8 ± 5.8 % of iron was 
present in the lipid phase in HbA-SUV sample and 28.0 ± 0.0 % in HbS-SUV sample. 
Figure 10. 
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A. The semi-logarithmic plot of free iron concentration(%) in HbA-SUV 
mixture as a function of time (h). The iron concentrations were 
determined by the foreseen assay. The iron concentration in the lipid 
phase was determined by subtracting the free iron concentration in the 
aqueous phase from the total free iron concentration. A. ■ total free iron 
concentration in HbA-SUV mixture t.. Free iron in the lipid phase in HbA-
SUV mixture, and O free iron in the aqueous phase in HbA-SUV 
mixture. B. v total free iron concentration in HbS-SUV mixture • Free 
iron in the lipid phase in HbS-SUV mixture, and ■ free iron in the 
aqueous phase in HbS-SUV mixture 
43 
Free Iron Release From Hb in the Presence of BPS SUVs 
a, 
~ 
= 
->C 
~ 
> :, 
u, 
I 
.0 
X 
.5 
-~ 0 
-C 
0 
~ 
a, 
a, 
~ 
u.. 
a, 
~ 
= 
->C 
~ 
> :, 
u, 
I 
.0 
X 
.5 
-,I.. 
-C 
0 
.: 
a, 
a, 
~ 
u.. 
In P110N 7.4 Buffer at PUHb. 800 and 37°C 
100 
A 
10 
-0-HbAFeAq 
-A-HbAFePI 
-■- HbA Fe Tot 
5.,_ ________________ __, 
0 2 4 
100 
B 
10 
5 
0 2 4 
8 
Time (h) 
8 
Time (h) 
8 10 
--
--■-HbS FeAq 
-e-HbSFePI 
V HbSFetot 
8 10 
44 
Within a period of 10 h, 76.9 ± 4.8 % of free iron partitioned into the lipid phase for 
HbA-SUV mixture, and 83.6 ± 1.0 % for HbS-SUV mixture. The t112 values for the 
iron partition into the lipid phase for both HbA and HbS was about 4.6 h. Thus after 
10 h most of the iron released from Hb was partitioned into the lipid phase, with slightly 
higher values for HbS-SUV mixture than for HbA-SUV mixture in Pll0N 7.4 buffer. 
The results obtained for the oxidative reactions in Pll0N 7.4 buffer conditions are 
summarized in Table 1. 
3.1. 7 MDA Assay 
The MDA assay showed a gradual increase in MDA levels in Rb-SUV system at 
phospholipid to Hb molar ratio of 800 in P110N7.4 buffer (Fig. 11). Both HbA and 
HbS systems exhibited similar rate of MDA formation. Initially about 0.4 µ.M MDA was 
detected and this value increased to 4 µ.Mat 2.5 h. The MDA concentration leveled to 
a maximum value of 6.22 ± 0.01 µM {n = 2) at 10 h for both HbA- and HbS-SUV 
mixtures. 
3.2 Oxidative Products Under Low pH and Low Ionic Strength Conditions (T5K 6.5 
Buffer) 
3.2.1 Disappearance of OxyHb 
Similarly the oxidation of Hb in T5K 6.5 buffer at phospholipid to Hb molar ratio 
of 360 and 4S was determined by analyzing the absorption spectra. A typical set of 
spectra obtained on HbA-SUV sample and HbS-SUV sample in T5K 6.S buffer at 
45 
Figure 11. Formation of MDA (µM) in a Hb + SUV mixture as a function of time 
(h). The Hb was incubated with BPS SUVs at phospholipid to Hb molar 
ratio of 800 and 37 °C in PllON 7.4 buffer. The production of MDA 
was determined by TBARS assay. ■ HbA + BPS SUV and □ HbS + 
BPS SUV. 
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Table 1. Summary of the First Order Rate Constants and t112 Values for the 
Disappearance of OxyHb, Disappearance of Heme and Appearance of Free Iron, 
Appearance of MDA and Cross-Linking of Hb in PllON 7.4 Buffer at PIJHb Molar 
Ratio of 800. 
Disappearance of oxyHb 
Disappearance of Heme 
Appearance of Free Iron 
Total Free Fe 
Free Fe in Aqueous Phase 
Free Fe in Lipid Phase 
Hb Cross-Linking 
MDA Formation 
First Order Rate 
Constants 
HbA HbS 
2.77±0.08• 2.70±0.09 
0.76±0.12 0.79±0.11 
N/Db N/D 
N/D N/D 
N/D N/D 
N/D N/D 
N/D N/D 
T1n (50 % Concentration) 
(h) 
HbA 
0.3 
0.8 
1.4 
0.8 
4.6 
3.5 
1.4 
HbS 
0.3 
0.8 
1.4 
0.8 
4.6 
3.5 
1.4 
a- Mean value of 2-3 measurments ± the standard deviation. 
b - Reaction was not first order. Thus the value was not obtained. 
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phospholipid to Hb molar ratio of 360 as a function of time (Fig. 12 A & B) shows a 
decrease in the two characteristic peaks for oxyHb at 577 and 565 nm and an increase 
in absorbance between 600 - 700 nm. The disappearance of oxyHb in HbA- or HbS-
SUV mixture in T5K6.5 buffer was found to be much faster than corresponding ones in 
P110N7.4 buffer at molar ratio of 800. In order to obtain reliable data, I decreased the 
rate by reducing the phospholipid to Hb molar ratio to 360 and determined the first order 
rate constants for the initial (up to 0.3 h) disappearance of oxyHb. The semi-
logarithmic plot of oxyHb concentration (%) versus time revealed a linear relationship 
during the initial phase (up to 0.3 h) of the reaction (Fig. 13). Linear fitting of the first 
9 data point provided a pseudo first order rate constant for the initial disappearance of 
oxyHb in the presence of SUVs. The mean rate constants were 0.84 + 0.1 h·1 (n = 4) 
for HbA, and 4.34 + 1.05 h·1 (n = 4) for HbS. The t112 for the initial disappearance 
of oxyHbS was 0.62 h for HbA and 0.2 h for HbS. I also monitored the oxidation of 
HbA and HbS at phospholipid to Hb molar ratio of 45 and obtained the rate constant of 
0.1 ± 0.01 h·1 (n = 4) for HbA, and 0.16 ± 0.02 h·1 (n = 4) for HbS (Fig. 13). 
Previous studies also show that HbS has a higher oxidation rate compared to HbA 
oxidation in T5K 6.5 buffer at phospholipid to Hb molar ratio of 45 in a Hb-LUV 
mixture. The observed rates of 0.25 ± 0.02 h·1 for HbA and 0.85 + 0.18 h·1 for HbS 
(Marva and Hebbel 1994). I obtained higher rate constants when buffers were not 
treated with chelex-100 to remove the trace metal ions or when glassware used was not 
acid washed. 
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Figure 12. Spectral changes from 500 - 700 nm of Hb02 + BPS SUVs in T5K 6.5 
buffer as a function of time at lipid to Hb molar ratio of 360 and 28 °c. 
The time intervals between each spectrum was 6 min, with the bottom 
spectrum taken immediately after mixing Hb02 and SUVs and the top 
spectrum taken at 45 min after mixing. Characteristic absorption peaks 
for oxyHb at 577 nm and 565 nm were observed at t = 0, and a 
prominent peak at 630 nm were observed at t = 45 min. A. HbA02 + 
BPS SUVs in T5K 6.5 buffer, and B. HbS~ + BPS SUVs in T5K 6.5 
buffer. 
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Figure 13. The semi-logarithmic plot of oxyHb concentration(% ) versus time (h) for 
the disappearance of Hb in the presence of BPS SUVs in T5K 6.5 buffer 
at lipid to Hb molar ratio of 360 and 28 °C. The value at each time point 
was the mean value of 4 experimental runs. ■ HbAO2 + BPS SUVs in 
T5K 6.5 buffer, and e HbSO2 + BPS SUVs in T5K 6.5 buffer at 
phospholipid to Hb molar ratio of 45 and ◊ HbAO2 + BPS SUVs in 
T5K 6.5 buffer and □ HbSO2 + BPS SUVs in T5K 6.5 buffer at 
phospholipid to Hb molar ratio of 360. 
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3.2.2 Disappearance of Heme /Porphyrins 
The fluorescence intensity of the porphyrin in Hb-SUV mixture, at molar ratio 
of 360, in TSK6.S buffer decreased with time (Fig. 14) in a manner similar to systems 
at molar ratio of 800 in P110N7.4 buffer. Pseudo first order rate constants for 
disappearance of heme at PL /Hb molar ratio of 360 were obtained by fitting the 
logarithmic values of heme concentration (%) versus time (t) to a linear equation. The 
rate constants that calculated were 0.63 ± 0.30 h-1 (n = 6) for HbA-SUV mixture and 
0.93 ± 0.30 h-1 (n = 6) for HbS-SUV mixture. At O.S h 43 % of heme was remaining 
in HbS reaction mixture and 73 % of heme was remaining in HbA reaction mixture (Fig. 
14). The t112 value was 1.1 h for HbA and 0.7 h for HbS. I saw a very little difference 
in rate constants between HbA and HbS at phospholipid to Hb ratio of 360, in TSK 6.5 
buffer. 
At phospholipid to Hb molar ratio of 45, the initial rate lasted for 0.7 h for both 
HbA and HbS (Fig. 14). I fitted the data in this region to linear equation and only 
marginal fit was obtained, as for the data with phospholipid to Hb ratio of 360. The first 
order rate constants for the destruction of heme were 0.37 ± 0.16 h·1 (n = 4) for HbA 
and 0.34 ± 0.09 h·1 (n = 4) for HbS. However due to the poor fit and the fact that the 
error bars were large, it was difficult to determine whether results of HbA differed from 
those of HbS. 
3.2.3 Heme Transfer into the Lipid Phase (SUVs) 
I observed a dramatic increase in the heme transfer to the lipid phase in T5K 6.5 
54 
Figure 14. The semi-logarithmic plot of heme concentration (%) versus time (h) in 
Hb- SUV mixture in T5K 6.5 buffer at lipid to Hb molar ratio of 360 
and 45 and at 28 °C. The heme concentration was determined by 
fluorescence spectroscopy. The fluorescence emission of the solution was 
obtained at 601 nm with the excitation at 405 nm. The values 
presentedwere mean values of 4 experimental runs. • HbAOi + BPS SUVs 
mixture in T5K 6.5 buffer, and ■ HbS02 + BPS SUVs mixture in T5K 
6.5 buffer at phospholipid to Hb molar ratio of 45 and O HbAOi + BPS 
SUVs in T5K 6.5 buffer and □ HbSOi + BPS SUVs in T5K 6.5 buffer 
at phospholipid to Hb molar ratio of 360. 
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Figure 15. The semi-logarithmic plot of free iron concentration (%) in Hb-SUV 
mixture as a function of time (h) in T5K 6.5 buffer at pbospbolipid to Hb 
molar ratio of 360 and incubated at 28 °C. The iron concentrations were 
determined by the foreseen assay. □ HbA-SUV mixture, o HbS-SUV 
mixture 
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buffer. Instead of - 1 % observed in PllON 7.4 buffer, 22.5 ± 0.7 % of heme 
transferred rapidly (t > 10 min) to the lipid phase upon mixing Hb and SUVs fot HbA 
and 94.3 ± 4.9 % for HbS. 
3.2.4 Appearance of Free Iron 
As for systems in P110N7.4 buffer, I was not able to fit the semi-logarithmic plot 
of free iron concentrations in T5K6.5 buffer as a function of time with a linear equation. 
Total free iron concentration increased as a function of time (Fig.15) in a manner similar 
to systems in P110N7.4 buffer. After 4 h incubation, 67. 7 + 1.0 % iron were found 
as free iron in HbA system and 71.6 ± 2.0 % in HbS system. The t112 values for the 
iron released from Hb in the presence of SUVs were 2.3 h for HbS and 1.5 h for HbA. 
The iron concentration in the lipid or aqueous phase were not determined for these 
systems in T5K 6.5 buffer. 
The results obtained for the oxidative reactions in T5K 6.5 buffer conditions are 
summariz.ed in Table 2. 
3.2.5 Globin Cross-Linking 
I also characterized the components in the oxidation reaction mixture by gel 
electrophoresis to detect Hb chains and cross-linked products in Hb-SUV mixture in T5K 
6.5 buffer at a phospholipid to Hb molar ratio of 360. The HbA- and HbS-SUV samples 
both showed bands at 15 kDa, 30 kDa and a faint band at 45 kDa soon after mixing (t 
- 5 min ) (Fig. 16 A & B). At t - 5 min I observed about 36 % of covalently cross-
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Table 2. Summary of the First Order Rate Constants and t112 Values for the 
Disappearance of OxyHb, Disappearance of Heme and Appearance of Free Iron and 
Cross-Linking of Hb in TSK 6.S Buffer at PIJHb Molar Ratio of 360. 
First Order Rate t112 (SO % Concentration) 
Constants (h•l) {h) 
HbA HbS HbA HbS 
Disappearance of oxyHb 0.84±0.10- 4.34±1.05 0.6 0.2 
Disappearance of Heme 0.63±0.30 0.93±0.30 1.1 0.7 
Total Free Iron Released N/Db N/D 1.4 2.2 
Hb Cross-Linking N/D N/D 1.4 0.3 
a- Mean value of 2-3 measurments + the standard deviation. 
b - Reaction was not first order. Thus the value was not obtained. 
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Figure 16. The 16 % SDS PAGE performed on the Hb-SUV mixture in TSK 6.S 
buffer at lipid to Hb molar of 360 and 28 °c, at different incubation times. 
The 50 µ.l of the sample was loaded to the gel. A. HbA-SUV mixture, 
B. HbS-SUV mixture 
SDS PAGE ofHb-SUV Mixture in T5K 6.5 Buffer 
at PL/Hb = 360 and 28 °C 
45kDa 
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Figure 17. The % of cross-linked Hb in the Hb-SUV mixture in TSK 6.5 buffer at 
lipid to Hb molar of 360 and 28 °c as a function of incubation time (h). 
The cross-linking was monitored by performing a 16 % SDS PAGE. The 
% intensity of each band was obtained by using Logitech Scan Man for 
scanning and Sigma Gel analyzing software for the gel % analysis. ■ 
HbA-SUV mixture and o HbS-SUV mixture as a function of incubation 
time (h). 
Cross-Linking of Hemoglobin in the Presence of BPS SUVs 
In T6K 6.6 Buffer at PUHb a 360 and 28°C 
-so 
'#. 
-C 
:a 
0 
-C) 
0 
160 / 
·-
-I UJ 
UJ 
~40~ 
0 1 
0/---0------------: 
/--■ 
2 3 
Time (h) 
-■-HbA+SUV 
-O-HbS+SUV 
4 6 
64 
linked Hb in the HbA-SUV mixture and 47 % in HbS-SUV mixture (Fig. 17). After 
prolonged incubation of the HbA-SUV mixture, cross-linking increased to 41.61 % at 
1 h, 63 % at 2 h, 70 % at 3 h, 71 % at 4 h and the cross-linking reached a plateau 
value of - 75 % at 5 h. The cross-linking of HbS appeared to be slightly faster with 
about 60 % at 1 h, , 73 % at 2 h, and 81 % fort = 3 -5 h. The t112 value for the 
cross-linking of Hb 0.25 h for the HbS-SUV mixture and 1.4 h for the HbA-SUV 
mixture, showing a difference between HbA and HbS in covalently cross-linking between 
their subunits. 
3.3 Globin-Heme Affinity 
I used apomyoglobin (apoMb) to extract heme from metHb to measure the heme 
and globin affinity in both HbA and HbS molecules under both Pl 10N7.4 and T5K6.5 
buffer conditions. The heme extraction profiles as a function of time in both P110N7.4 
and T5K6.5 buffers at 25°C were similar (Fig. 18 and Fig.19 respectively). A fast 
phase kinetic followed by a slow phase kinetic was observed. These results were 
qualitatively similar to those published with an initial fast phase kinetics, which was 
attributed to heme extraction from ~-chains, followed by a slower phase which attributed 
to heme extraction from a-chains (Benesch and Kwong, 1990). I used the time for 25 
percent of the heme to be transferred to apoMb (Benesch and Kwong, 1990) to represent 
rates of the heme transfer. The time taken for 25 % of the heme to be transferred from 
metHbA to apoMb in Pll0N 7.4 buffer was 1.7 ± 0.2 h (n = 3) and that for metHbS 
was 1.6 ± 0.1 h (n = 3) (Fig. 18). The heme release from Hb in the T5K 6.5 buffer 
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Figure 18. The heme partitioning into apomyoglobin from metHb as a function of 
time in PllON 7.4 buffer. MetHb and apoMb was mixed in a 1: 5 molar ratio and was 
incubated at 25 ° C. An increase in absorbance at 409 nm was monitotred as an 
indication of heme being coordinated to apoMb. Heme containing Mb at the same 
concentration as metHb was used to give absorbance reading for 100 % heme transfer. 
The ratio of absorbance difference for apoMb and Mb (%) were used to represent heme 
transferred from Hb to apoMb. ■ HbA + apoMb and o HbS + apoMb 
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Figure 19. The heme partitioning into apomyoglobin from metHb as a function of 
time in T5K 6.5 buffer. MetHb and apoMb was mixed in a 1: 5 molar 
ratio and was incubated at 25 ° C. An increase in absorbance at 409 nm 
was monitotred as an indication of heme being coordinated to apoMb. 
Heme containing Mb at the same concentration as metHb was used to give 
absorbance reading for 100 % heme transfer. The ratio of absorbance 
difference for apoMb and Mb (%) were used to represent heme transferred 
from Hb to apoMb. ■ HbA + apoMb and o HbS + apoMb. 
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Figure 20. Heme partitioning into the lipid phase as a function of ionic strength and 
osmolarity. The Hb in Hb + BPS SUV mixture in the experimental buffer 
was mixed with SUV to Hb molar ratio of 360, and 200 was immediately 
separated on a superose 12 FPLC column. The lipid fraction was collected, 
and the heme concentration in he lipid phase was determined. Values were 
presented as a percentage of heme partitioned into the lipid phase. • 
HbA + BPS SUV and ■ HbS + BPS SUV in tris buffer at 70, 90 and 
130 osmolarity (mmol/kg) at phospholipid to Hb molar ratio of 200, V 
HbA + BPS SUV and ◊ HbS + BPS SUV in T5N 6.5 buffer at 
phospholipid SUV in T5K 6.5 buffer at phospholipid to Hb molar ratio of 
360. 
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was 3.2 + 0.2 h (n = 2) for metHbS and 3.8 ± 0.0 h (n = 2) for metHbA (Fig. 19). 
I observed that at low pH and low ionic strength conditions less heme transferred to 
apoMb compared to that of in high pH and higher ionic strength. A small difference 
between HbA and HbS was observed in T5K 6.5 buffer. These results are similar to the 
previously reported values of heme transfer under low pH which are due to the decrease 
in the affinity between free heme and apoMb at low pH (Benesch and Kwong, 1990). 
3.4 Ionic Strength and pH Effects on Heme Transfer in Hb-SUV Systems 
Since the heme transfer from Hb to lipid phase in P110N7.4 buffer was found to 
be very different from that in T5K6.5 buffer for both HbA and HbS -SUV systems, I 
also studied the heme transfer as a function of ionic strength and pH in both phosphate 
and tris buffer systems. Since phosphate buffers were prepared with 35 mM phosphate, 
whereas tris buffers were prepared with 10 mM tris, osmolarities rather than salt 
concentrations were used to show ionic strength effects on heme concentrations in the 
lipid phase. As shown in Fig. 20 and Fig. 21, a strong osmolarity dependent was 
observed for the HbS system in tris buffers. In addition, a large difference in heme 
concentrations in lipid phase was observed between HbA and HbS systems at low 
osmolarities. Replacement of KCl with NaCl did not affect the heme concentrations in 
the lipid phase. For HbS systems, 97 + 7 % (n = 2) of heme were found in the lipid 
phase in T5K6.5 buffer and 100 ± 0 % (n = 2) in T5N6.5 buffer (Fig. 20). For HbA 
systems, 26 ± 5 % (n = 4) heme was released from Hb in T5K6.5 buffer and 29 ± 
0 % (n = 2) in T5N6.5 buffer. I observed little difference between the results obtained 
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for T5K 6.5 buffer systems and in T5N 6.5 buffer systems. This indicated that the use 
of KCl or NaCl did not affect the amount of the heme release. In T20K 6.5 buffer, I 
observed 50 ± 5 % (n =3) heme was transferred to the lipid phase for HbS-SUV 
mixture and 20 + 1 % (n =2) for the HbA-SUV system. In T85K 6.5 buffer, 21 ± 1 
% (n = 2) of heme was transferred into the lipid phase for HbS system and 11 ± 2 % 
(n = 2) for HbA-SUV system. I observed, with the increase of the ionic strength, the 
extent of heme transfer decreased and the differences between heme transferred in HbA 
and HbS system decreased. 
The concentrations of heme in the lipid phase decreased as pH increased. For 
HbS systems, at pH 6.5, 28 ± 6 % (n = 3) of the heme were found in the lipid phase 
in P10N6.5 buffer, but at pH 7.4 only 3 + 0 % (n = 3) were found in P10N7.4 buffer 
(Fig. 21). For HbA system, at pH 6.5, 16 + 3 % (n = 3) heme were found in the lipid 
phase in P10N6.5 buffer, but at pH 7.4 only 3 ± 1 % (n = 2) in Pl0N7.4 buffer. 
Thus in phosphate buffer with 10 mM NaCl, a difference in heme concentrations in lipid 
phase was observed at pH 6.5 between HbA and HbS systems, but not at pH 7.4. Under 
physiological ionic strength and pH, very little heme was found in the lipid phase in both 
the HbA and HbS systems. In P0N6.5 buffer 24 ± 2 % (n = 3) heme was transferred 
into the lipid phase for HbS system and 10 + 3 % (n = 3) for the HbA system. In 
P50K 6.5 buffer 9.02 ± 1 % (n = 3) heme was transferred into the lipid phase for HbS 
and 11 ± 1 % for HbA system. Similarly, in phosphate buffers I observed that the 
extent of heme transfer decreases with the increase of ionic strength. At low ionic 
strength phosphate buffers (PON6.5 and P10N6.5) I observed differences between the 
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Figure 21. Heme partitioning into the lipid phase as a function of ionic strength and 
osmolarity. The Hb in Hb + BPS SUV mixture in the experimental buffer 
was mixed with SUV to Hb molar ratio of 800, and 200 and was 
immediately separated on a Superose 12 FPLC column. The lipid fraction 
was collected, and the heme concentration in the lipid phase was 
determined. The values were presented as a percentage of heme from the 
initial heme in the reaction mixture. • HbA + BPS SUV and ■ HbS 
+ BPS SUV in phosphate buffer at 70, 90 andl30 osmolarity (mmol/kg) 
at phospholipid to Hb molar ratio of 200. 0 HbA + BPS SUV and □ 
HbS + BPS SUV in PllON 7.4 buffer at phospholipid to Hb molar ratio 
of 800 and ◊ HbA + BPS SUV and V HbS + BPS SUV in PION 7.4 
buffer. 
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HbS and HbA systems. As the ionic strength and/or pH was increased (PSON6.S and 
PlON7.4) the HbA and HbS systems exhibited similar values for the heme transfer. The 
results are summariz.ed in Table 3. 
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Table 3. Heme(%) Transfer into BPS SUVs Under Different Buffer Conditions 
Buffer Osmolarity PU Hb n" % Heme %Heme(IN/ 
(mmoles/kg) Hb % Heme(HbA> 
PON 6.5 70 200 HbA 3 10.2+3.2· 2.4 
HbS 3 24.3±2.1 
Pl0N 6.5 90 200 HbA 3 15.6±3.8 1.7 
HbS 3 26.7±4.6 
P50N 6.5 130 200 HbA 3 10.0±1.0 1.1 
HbS 3 10.7±0.6 
Pl0N 7.4 90 200 HbA 2 6.0± 0.0 1.0 
HbS 3 6.0+1.0 
Pll0N 7.4 240 800 HbA 2 1.0±0.0 1.0 
HbS 2 1.0±0.0 
T5K 6.5 70 360 HbA 3 22.5±0.7 4.2 
HbS 3 94.3±4.9 
T5K 6.5 70 200 HbA 2 28.3±2.2 3.4 
HbS 4 97.4±4.6 
T5N 6.5 70 200 HbA 2 28.5±0.1 3.5 
HbS 2 100±0.0 
120K 6.5 90 200 HbA 2 20.0±1.4 2.5 
HbS 3 50.3±5.1 
T85K 6.5 130 200 HbA 2 10.5±2.1 2.0 
HbS 2 20.5±0.7 
a- Mean value of 2-3 measurments ± the standard deviation 
b- Number of individual runs 
CHAPTER IV 
DISCUSSION 
Oxidation of oxyHb in aqueous solution is complex and involves many 
intermediate species, including metHb, hemichrome, choleglobin, superoxide anion, 
hydrogen peroxide, hydroxyl radical, etc. (Winterbourn, 1990b; Winterbourn 1985b). 
And some of these intermediate species include a subset of compounds. For example, 
hemichrome is a general classification of many different compounds (Peisach and 
Blumberg, 1975) and choleglobin is often not well defined (Winterbourn, 1990b; Pacifici 
et al., 1993). Oxidation of oxyHb in the presence of lipid surface is further complicated 
not only by additional intermediate species from lipid molecules but also by reactions in 
the aqueous phase and in the lipid phase. The presence of a lipid phase also promotes 
the disappearance of oxyHb (LaBrake and Fung, 1993) and the accumulation of 
hydrophobic species such as heme and porphyrin in the lipid phase. In this study, we 
systematically monitored the disappearance of oxyHb and the formation of three 
intermediate species in oxyHb and SUV mixtures to further our understanding of the 
oxidative reactions of oxyHb in the presence of lipid surface under different buffer 
conditions. These three intermediates were heme/porphyrin, free iron ion and MDA. 
The iron concentration in both the lipid and aqueous phase was monitored. 
My results support the earlier finding that lipid surface enhances oxyHb 
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disappearance and metHb formation. In a system consisting of simply oxyHb and lipid 
molecules (with no or little initial Hb oxidation and lipid peroxidation products) the lipid 
surface enhances the oxidation of oxyHb. When the oxyHb-SUV mixture was incubated 
in physiological buffer (Pll0N 7.4) the disappearance of oxyHbA was observed 
immediately after mixing, with a pseudo first order rate constant of 2.8 h·1• I also 
observed the Hb undergoing cross-linking immediately after mixing (30 % cross-linked 
Hb products at - 5 min). Subsequent to the disappearance of oxyHbA, I observed the 
disappearance of heme, with a first order rate constant of 0.8 h·1, and the appearance of 
free iron. The data on the appearance of iron could not be fitted to first order reaction 
kinetics. At 0.3 h about half of the oxyHb was disappeared and, at 0.8 h about half of 
the heme was disappeared and at about 1.3 h 50 % of the heme iron was detected as free 
iron (iron free from Hb). 
The oxygen radicals (02) formed during the process of the Hb oxidation were 
more likely to react at its generation site. Therefor the decrease in the heme 
concentration that I detected was probably due to the presence of these oxygen radical, 
since reactions between heme and oxygen radicals lead to the destruction of the porphyrin 
(Cantoni et al., 1981). The first step of the destruction of porphyrin would be the 
cleavage of the methylene bridge of the porphyrin ring carbon which leads to the 
formation of biliverdin. Since biliverdin undergoes further oxidation, resulting in the 
formation of smaller fragments (Brown and Jones, 1968), I did not detect any biliverdin 
in our reaction mixture. The destruction of heme caused the release of free iron from 
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Hb. 
One of the most interesting findings was the distribution of the iron released from 
Hb molecules. As expected iron concentrations in Hb-SUV mixtures increased as a 
function of time. However,iron concentrations in the aqueous phase reached a maximum 
value of 30 - 40 % at about 2.5 h before decreasing to only about 24 % at 10 h. Initially 
the iron concentrations in the lipid phase increased with slightly slower rates than that 
in the aqueous phase, but the concentration continued to increase after 2.5 hand reached 
almost 100 % at 10 h. The t112 value for total Fe release was found to be 1.3 h. 
As a consequence of the accumulation of iron ions in the lipid phase, lipid 
peroxidation became significant. MDA concentration increased rapidly and exhibited a 
10 fold increase (4µM) at 2.5 h. At the end of 10 h, about 6 µM of MDA was 
detected. It was interesting to see that the t112 of the MDA formation was 1.4 h, a value 
very similar to that of iron release. 
At t = 2 h when about 30 % of iron were found in the lipid phase, substantial 
amount of lipid was degraded. A 
fraction with molecular masses much smaller than Hb (2-3 kDa) was separated from 
other oxidative components. This fraction exhibited a sharp absorption at 265 nm 
suggesting the presence of conjugated carbonyl groups. 
The initial cross-linking of globin chains was much faster than the appearance of 
iron. Immediately after mixing of oxyHb with SUVs, about 36 % of globin already 
appeared to be crossed-linked (mostly between chains within the Hb tetra.mer such that 
the molecular mass remained as 64 kDa). During this time interval, disappearance of 
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oxyHb was detected. Thus the cross-linking of globin chains was probably due to the 
generation of oxygen radicals but not necessarily in the presence of iron. Previous 
studies show that the reaction of Hb with H2O2 lead to the formation of ferryl-Hb {Fe4+). 
The Fe4+ in ferryl-Hb can undergo electron transfer with neighboring amino acid tyrosine 
42 forming a radical on the tyrosine 42 residue (McArthur and Davies, 1993). This 
radical may initiate the formation of radicals on other tyrosine residues in globin subunits 
leading to the formation of a bi-tyrosine cross-link and the association of subunits in the 
Hb molecule (Giulivi et al., 1994; Pacifici et al., 1993). 
It is interesting to compare the results from HbA with those from HbS since HbS 
has been considered to exhibit faster oxidation rates that lead to membrane abnormalities 
(Hebble, 1986; Marva and Hebbel, 1994). However I found little difference between 
HbA and HbS in buffers under physiological conditions (P 11 0N7. 4) in the disappearance 
of oxyHb, Hb cross-linking, heme destruction, Fe release MDA formation and heme 
release into the lipid phase. All the t1n values and the rate constant obtained for HbS 
were found to be very similar to those of HbA. 
Under low salt and low pH conditions (T5K6.5), the disappearance of oxyHb was 
considerably faster than in high salt, high pH buffer condition. Since the oxidation 
reaction under low salt low pH buffer condition was fast, we reduced the phospholipid 
to Hb molar ratio from 800 to 360 to slow down the reaction to monitor and compare 
the kinetics between HbS and HbA reliably. The oxidation rate constants were 4.34 h·1 
for HbS and 0.84 h·1 for HbA, showing a 5.2 times increase in HbS system. We also 
observed a difference in the cross-linking of Hb subunits in HbA and HbS systems. 
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The destruction of heme in the presence of SUVs did not show much difference 
between the two Hbs. Since the destruction of Hb led to the release of free iron, we also 
did not see differences in the release of total free iron. We believe that the destruction 
of heme could proceed when heme is in either the aqueous phase or the lipid phase. 
The heme transfer into SUV from HbS and HbA showed no difference in Pll0N 
7.4 buffer but showed a drastic difference in T5K 6.5 buffer. The heme transfer from 
HbS was 10 times greater in HbS-SUV system than from HbA in HbA-SUV system in 
T5K 6.5 buffer. The difference could not be explained by the globin-heme affinity in 
HbS in T5K6.5, since we found that both HbA and HbS exhibited similar heme-globin 
affinity in both P110N7.4 and T5K6.5 buffers, as determined by apomyoglobin-heme 
extraction. At lower pH (T5K 6.5), we observed that less heme (30 % ) was extracted 
by apoMb as compared to 50 % in high salt high pH buffer conditions (Pll0N 7.4). 
This is probably due to reduced affinity of heme towards apoMb at low pH (Benesch and 
Kwong, 1990). 
Heme partitioning into the lipid phase may be represented by two steps. First, 
heme release from the globin to the aqueous phase, and then the free heme is transferred 
to a heme acceptor (Smith et al., 1984). The heme transfer from Hb is biphasic. The 
fast phase is the release of heme from /3 chains and slow phase represents the release 
from<¥ chains (Paul et al., 1991). The Fe2+- proximal histidine covalent bond in oxyHb 
prevents the heme loss from globin (Whitaker et al., 1995) and also histidine 64, valine 
68 and porphyrin interactions inhibit the release of heme (Hargrove et al., 1994). My 
results showed that heme from Hb partitioning into apoMb was a rather a slow process 
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under both physiological and non-physiological buffer conditions. In 150 mM phosphate 
buffer at pH 7.0 a complete release of heme occurs within 3 -4 days (Hargrove.et al., 
1994). Due to the protonation of the proximal histidine under low pH conditions the 
release of heme is much faster than at physiological pH (Hargrove et al., 1994). I did 
not see much difference in the rate of heme release between HbA and HbS in P110N 7.4 
buffer or in T5K 6.5 buffer Qow salt and low pH); although we observed a large 
difference in the heme transfer into the lipid phase between HbA and HbS in T5K 6.5 
buffer. 
It has been found that CO-heme partitions between the external solvent phase and 
the outer lipid layer of the membrane at a rapid rate (rate constant of about 7 x HP M·1 
s·1). The rate limiting steps of this reaction are the separation of heme from the globin 
and the solvation of the heme in the aqueous phase (Smith et al., 1991). Since I did not 
see much difference in the heme release into the aqueous phase under both buffer 
conditions we believe that the rate for the heme-proximal histidine bond breaking and the 
heme solvation in the aqueous phase to be the same for both HbA and HbS. I observed 
a difference in the acceptance of the heme by the SUV at low salt and low pH buffer 
conditions. It appearers that the ionic strength affects the heme transfer into the lipid 
phase. I observed that the release of heme into the lipid phase drastically decreased as 
the KCl concentration (osmolarity) was increased in tris buffers. Similarly when the 
osmolarity of the phosphate buffers were increased I observed a decreased in the heme 
transfer as well as a decrease in the differences between HbA and HbS. 
It is also interesting to discuss the effects of tris and the phosphate buffers. I 
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clearly showed that tris buffers have a greater effect on heme transfer as compared to 
phosphate buffers. Previous investigations showed that tris buffers could cause many 
adverse effects on the proteins (Bubb et al., 1995; Gillespie and McKnight, 1976). They 
showed that tris(2-amino-2-hydroxymethylpropane-1-3-diol), can react with proteins and 
small molecules as aldehydes. Pinder and co workers ( 1995) showed the use of tris 
solutions as a denaturating agent similar to guanidinium chloride, for depolymeriz.atiion 
of proteins. The capability of tris to form complexes with a wide range of metal ions 
(group IlA metals and transition metals) (Scheller et al., 1980) may produce adverse 
effects on Hb oxidation. Since the presence of metal ions have shown to enhance the 
oxidation of Hb (Winterboum and Carrell, 1977) 
Differences between HbA and HbS in oxidative reactions (disappearance of 
oxyHb, Hb cross-linking and heme transfer into SUVs) were mostly at low salt and low 
pH conditions. The heme transfer experiments performed at different osmolarities 
showed that an increase in the Cl" concentration decreased the.heme transfer into the lipid 
phase. This is probably due to a stabilizing effect of the CI· ions on the globin structure. 
Previous studies have shown that the denaturation of myoglobin occur much faster under 
low salt (Cl") and low pH conditions (Loh et al., 1995). Since Mb and Hb have similar 
structural characteristics one can assume that the CI· effects on Hb structure are similar 
to those on Mb structure. The c1· stabilizes the helical structure of the proteins and at 
low c1· concentration B, C, E and H helices are unfolded (Loh et al., 1995). Unfolding 
the E helix changes the conformation of the distal histidine (F8 -histidine) and causes 
the exposure of the heme to the aqueous environment, leading to an increase Fe2+ 
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oxidation and the release of heme. Oxidation of Hb leads to conformational changes in 
F and E helices (Dong et. al. 1995). Whitaker et al. (1995) showed that in the absence 
of the D helix in Mb the mobility of C- and E-helices increased and the rate of hemin 
loss increased by 50-fold. These helices (E and F) carry the proximal histidine (F8) and 
the distal histidine (E7). The orientation of these histidine residues are very important 
in the retention of heme at the heme pocket (Hargrove et al., 1994). Oxidation Fe2+ to 
pe3+ in Hb weakens the proximal histidine-Fe bond and releases the heme from the 
oxidized Hb. Protonation of the histidine residues under low pH also makes the release 
of heme easier. HbS molecule exhibits a higher surface activity and more surface 
hydrophobicity than HbA (Hirsch et al., 1980). It is also shown that HbS has a greater 
affinity towards the membrane compared to HbA (Fung et al., 1975). These studies 
showed that under low pH and low salt conditions (5 mM phosphate at pH 6.0) HbS had 
a greater affinity towards the membrane and upon addition of Ct, under high salt high 
pH (physiological) conditions HbS had a lower affinity towards membrane. Since HbS 
interacts with SUV to a greater extent compared to HbA especially at low salt and low 
pH buffer conditions it is possible for the HbS as compared to HbA, to have a higher 
rate of oxidation and a higher reactivity towards SUV s. 
Results also show that SUVs act as a better heme acceptor than aJX>Mb. It has 
been suggested that the carboxylic side chains and the Fe3+ atom in the porphyrin (heme) 
occupies site close to phospholipid head groups when partitioned into the lipid bilayer 
(Kurelova and Brault, 1994; Tipping et al., 1979) and the dimethyl-divinyl "end" of the 
heme is immersed into the hydrocarbon region (Tipping et al., 1979). 
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I saw very little differences between HbA and HbS-systems that the disappearance 
of heme and in the release of total free iron. Since I argue that the iron is the major 
little differences in the lipid peroxidation in these two systems are expected even at low 
ionic strengths. 
HbS has a mutation at the (j6 position. ~6 glutamic acid is substituted by valine. 
The most prominent feature of the HbS is the polymerization of deoxyHbS. Crystal 
structure did not show differences between oxyHbA and oxyHbS. NMR studies showed 
some irregulations on some surface residues in HbS in both oxy and deoxy states, but no 
structural differences at the heme pocket was observed (Fung et al., 197S). Fronticelli 
(1978) showed differences between the CD spectra of HbA and HbS at the soret region 
which were believed to be due to the changes in the~ globin chain. It is also found that 
the ~ globin chains of HbA has a higher affinity to the a globin chains than the ~ globin 
chains of HbS, giving HbA a higher tetra.mer stability than HbS (Shaeffer, 1980). It is 
believed that the abnormalities observed in the sickle cell membrane is due to the faster 
rate of oxidation in HbS (Hebbel, 1986). My experiments show that under physiological 
conditions HbS does not undergo higher rate of oxidation to give membrane 
abnormalities. However faster disappearance of oxyHb in HbS was observed at pH and 
low ionic strength. Differences were also observed on Hb cross-linking and heme release 
from Hb into SUVs. When the sickle RBCs undergo some cellular change to cause the 
pH and the ionic strength to be lowered, faster oxidation in HbS are expected. This 
increase in the oxidation of HbS could lead to the higher level of Hb cross-linking and 
heme release from Hb. However little difference in the heme destruction and in the free 
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iron release from Hb even under low pH and low ionic strength was observed between 
HbA and HbS. Thus it is possible that the abnormalities in sickle erythrocyte membranes 
are due to the Hb denaturation (Hb cross-linking) leading to the buildup of hemichrome 
in the RBC membrane and not due to abnormal lipid peroxidation. 
Results obtained from these studies also provide insight towards the development 
of blood substitute using liposome encapsulated Hb. Research efforts on blood substitute 
have mainly focused on oxygen binding capacity and stability of Hb at low temperatures 
(Tsuchida, 1994). An important factor to consider is the release of free iron from Hb 
which may cause many toxic effects on the endothelial cell. I believe it is also important 
to avoid non-physiological buffers such as tris since these buffers may initiate destructive 
reactions in the Hb-liposome systems. 
REFERENCES 
Alayash, A. I., and Cashon, R. E. (1995) Hemoglobin and free radicals: implications 
for the development of a safe blood substitute. Mol. Med. Today 1, 122-127. 
Benesch, R. E., and Kwong, S. (1990) The stability of the heme-globin linkage in 
some normal, mutant, and chemically modified hemoglobin. J. Biol. Chem. 265, 
14881-14885. 
Brown, S. P., and Jones, P., (1968) Reaction between haemin and hydrogen 
peroxide. Tras. Faraday soc. 64, 994-1005. 
Bubb, W. J., Berthon, H. A., and Kuchel, P. W. (1995) Tris buffer reactivity with 
low-molecular weight aldehydes: NMR charactemation of the glyceraldehyde 3-
phosphate. Bioorg. Chem. 23, 119-130. 
Buege, J. A., and Aust, S. D. (1978) Microsomal lipid peroxidation. Methods in 
enzymology 217, 302-310. 
Bunn, H. F. (1993) The use of Hemoglobin as a blood substitute. Am. J. Hematol. 
42, 112-117. 
Cantoni, L., Gibbs, A.H., and De Matteis, F. (1981) Loss of heme and 
haemproteins during the generation of superoxide anion and hydrogen peroxide: a 
pathway not involving production of carbon monoxide. Int. J. Biochem. 13, 823-830. 
Carter, P. E. (1971) Spectrophotometric determination of serum iron at the 
submicrogram level with a new reagent (ferrozine). Anal. Biochem. 40, 450-458. 
Chiu, D., and Lubin, B. (1989) Oxidative hemoglobin denaturation and RBC 
destruction: The effect of heme on red cell membranes. Seminars in Hematol. 26, 
128-135. 
Chiu, D., Lubin, B., and Shohet, S. B. (1982) Peroxidative reaction in red cell 
biology. In Free Radicals in Biology Proyer W. A. (Ed), Academic Press. Inc, New 
York, Vol.5, 115-160. 
Dong, A., Huang, P., Caughey, B., and Caughey, W. S. (1995) Infrared analysis of 
ligand and oxidation induced conformational changes in hemoglobin and myoglobin. 
Arch. Biochem. Biophys. 316, 893-898. 
87 
88 
Fenton, H. 1. H. (1894) Oxidation of tartaric acid in the presence of iron. J. Chem. 
Soc. 65, 899-910. 
Fronticelli, C. (1978) Effect of the {16 Glu-Val mutation on the optical activity of 
hemoglobin Sand its fJ subunits. J. Biol. Chem. 253, 2288-2291. 
Fung, L. W. -M., Chao-Lin, K. L., and Ho, C. (1975) High- resolution proton 
nuclear magnetic resonance study of sickle hemoglobin. Biochemistry 14, 3424-3430 
Gillespie, 1. S., and McKnight, A. T. (1976) Adverse effect of tris hydrochloride, a 
commonly used buffer in physiological media. J. Physiol. 259, 561-573. 
Giulivi, C., Pacifici, R. E., and Davies, J. A. (1994) Exposure of hydrophobic 
moieties promotes the selective degradation of hydrogen peroxide-modified 
hemoglobin by the multicatalytic proteinase complex, proteasome. Arch. Biochem. 
Biophys. 311, 329-341. 
Gutteridge, 1. M. C., Quinlan, G. 1., Swain, 1., and Cox, 1. (1994) Ferrous ion 
formation by ferrioxamine prepared from aged desferrioxamine: A potential 
prooxidant property. Free Rad. Biol. Med. 16, 733-739. 
Haber, F., and Weiss, 1. 1. (1934) The catalytic decomposition of H20z by iron salts. 
Proc. R. Soc. London. A147, 332-351. 
Halliwell, B., and Gutteridge, 1. M. C. (1985) The importance of free radicals and 
catalytic metal ions in human diseases. Mol. Aspects Med. 8, 89-193. 
Hargrove, M. S., Singleton, E. W., Quillin, M. L., Ortiz, L. A., Phillips, G. N., 
and Olson, 1. S., (1994), His64 (E7)-Tyr Apomyglobin as a regent for measuring 
rates of hemin dissociation, J. Biol. Chem. 269, 4207-4214. 
Hebbel R. P. (1986) autoxidation and the sickle erythrocyte membrane: A possible 
model of iron decompartmentalization. In Free Rad., Aging. Dege. Dise. Jhonson, 1. 
E., Walford, R., and Harman, D., Eds., Liss Inc., New York, 395-424. 
Hebbel, R. P., and :Eaton, 1. W. (1989) Pathobiology of heme interaction with the 
erythrocyte membrane. Seminars in Hematol. 26, 136-149. 
Hirsch, R. L., Elbaum, D., Brody, S. S., and Nagel, R. L. (1980) oxyhemoglobin A 
and Oxyhemoglobin S films at an air- water interface: Absorption spectra studies. J. 
Colloid Interface Sci. 78, 212-216. 
Kanner, 1., and Harel, S. (1985) lipid peroxidation and oxidation of several 
compounds by H20z activated metmyoglobin. Lipids, 20, 625-628. 
89 
Kim, R. S., and La.Bella, F. (1987) Comparison of analytical methods for monitoring 
autoxidation profiles of authentic lipids. J. lipid Res. 28, 1110-1117. 
Kosa.ka, H., and Tyuma, I. (1982) Production of superoxide anion by N, N-bis(2-
hydroxyethyl)-iminotris(hydroxymethyl)methane buffer during oxidation of 
oxyhemoglobin by nitrite and effect of inositol hexaphosphate on the oxidation. 
Biochim. Biophys. Acta 709, 187-193. 
Kurros, S. A., and Hebbel, R., P., (1988) Nonheme iron in sickle erythrocyte 
membranes: Association with phospholipid and potential role in lipid peroxidation. 
Blood 12, 1278-1285. 
Kuzelova,K., and Brault, D. (1994) Kinetic and equilibrium studies of porphyrin 
interactions with unilamellar lipidic vesicles, Biochemistry, 33, 9447-9459. 
LaBrake, C. C., and Fung, L., M.-W. (1992) Phospholipid vesicles promote human 
hemoglobin oxidation. J. Biol. Chem. 267, 16703-16711. 
Loh, S. N., Kay, M. S., and Baldwin, R. L. (1995) Structure and stability of a 
second molten globule intermediate in the apomyoglobin folding pathway. Proc. Natl. 
Acad. Sci. USA 92, 5446-5450. 
Marva, E., and Hebbel, R. P. (1994) denaturing interaction between sickle 
hemoglobin and phosphotidylserine liposomes. Blood 83, 242-249. 
Mayer, L. D., Hope, M. J., and Cullis, P. R. (1986) Vesicles of variable sizes 
produced by a rapid extrusion procedure. Biochim. Biophys. Acta 858, 161-168. 
McArthur, K. M., and Davies, M. J. (1993) Detection and reaction of the globin 
radical in haemoglobin. Biochim. Biophys. Acta 1202, 173-181. 
Minotti, G., and Aust, S. D. (1987) The requirement for iron(lll) in the initiation of 
lipid peroxidation by iron(l l) and hydrogen peroxide. J. Biol. Chem. 262, 1098-
1104. 
Misra, H. P., and Fridovich, I. (1972) The generation of superoxide radical during 
the autoxidation of hemoglobin. J. Biol. Chem. 247, 6960-6962. 
Pacifici, R. E., Kono, Y., and Davies, K. J. A. (1993) Hydrophobicity as the signal 
for selective degradation of hydroxyl radical-modified hemoglobin by the 
multicatalytic proteinase complex proteasome. J. Biol. Chem. 268, 15405-15411. 
Paul, J., Smith, M. L., and Paul, K. G. (1991) Fast heme release from inactive 
proteins. Biochim. Biophys. Acta 1079, 330-334. 
90 
Peisach, J., Blumberg, W. E., and Rachmilewitz, E. A. (1975) The demonstration of 
ferrihemochrome intermediates in Heinz body formation following the reduction of 
oxyhemoglobin A by acetylphenylhydrazine. Biochem. Biophys. Acta. 393, 404-418. 
Perutz, M. F. (1972) Nature of heme-heme interaction. Nature 237, 495-499. 
Pinder, J. C., Sleep, J. A., Bennett, P. M., and Gratzer, W. B. (1995) Concentrated 
tris solutions for the preparation, depolymerization, and assay of action: application to 
erythroid actin. Anly. Biochem. 225, 291-295. 
Puppo, A., and Halliwell, B. (1988) Formation of hydroxyl radicals from hydrogen 
peroxide in the presence of iron. Biochem. J. 249, 185-190. 
Rabinovici, R., Rudolph, A. S., Yue, T.-L., and Feuerstein, G. (1990) Biological 
responses to liposome-encapsulated hemoglobin (LEH) are improved by a P AF 
antagonist. Circulatory Shock 31, 431-445. 
Repka, T., Shalev, 0., Reddy, R., Yuan, J., Abrahamov, A., Rachmilewitz, E. A., 
Low, P. S., and Hebbel, R. P. (1993) Nonrandom association of free iron with 
membranes of sickle and fJ-thalassemic erythrocytes. Blood 82, 3204-3210. 
Rudolph, A. S. (1988) The freeze-dried preservation of liposome encapsulated 
hemoglobin: A potential blood substitute. Cryobiology 25, 277-284. 
Scheller, K. H., Abel, T. H. J., Polanyi, P. E., Wenk, P. K., Fischer, B. E., and 
Sigel, H. (1980) Metal ion/buffer interaction. Eur. J. Biochem. 107, 455-466. 
Schwartz, S., Dahl, J., Ellefson, M., and Ahlquist, D. (1983) The hemoquant test: A 
specific and quantitative determination of heme in feces and other material. Clin. 
Chem. 29, 2061-2067. 
Sevanian, A., and Hochstein, P. (1985) mechanism and consequences of lipid 
peroxidation in biological systems. Ann. Rev. Nutr. 5, 365-390. 
Shaeffer, J. R. (1980) Evidence for a difference in affinities of human hemoglobin fJA 
and /J8 chains for a chains. J. Biol. Chem. 255, 2322-2324. 
Shaldai, N., Sharma, V. S., and Ranney, H. M. (1981) Interaction of sickle cell 
hemoglobin with erythrocyte membranes. Proc. Natl. Acad. Sci. USA 78, 65-68. 
Smith, M. L., Hjortsburg, K., Romeo, P.-H., Rosa, J., and Paul, K-G. (1984) 
Mutant hemoglobin stability depends upon location and nature of single point 
mutation. FEBS Le11. 169, 147-150. 
91 
Smith, M. L., Paul J., Ohlsson, P. I., Hjortsburg, K., and Paul, K-G. (1991) Heme-
protein fission under nondenaturing conditions. Proc. NOJl. Acod. Sci. USA 88, 882-
886. 
Stewart, J. C. M. (1980) Calorimetric determination of phospholipid with ammonium 
ferrothiocyanate. Anal. Biochem. 104, 10-14. 
Stocks, J., and Dormandy, T. L. (1971) The autoxidation of human red cell lipids 
induced by hydrogen peroxide. British J. of Haem01ol. 20, 95-111. 
Sugawara, Y., Sakoda, M., Shibata, N., and Sakamoto, H. (1993) Autoxidation of 
human hemoglobin: kinetic analysis of the pH profile. Japanese J. Physiol. 43, 21-
34. 
Szebeni, J., and Toth, T. (1986) Lipid peroxidation in hemoglobin-containing 
liposomes. Effects of membrane phospholipid composition and cholesterol content. 
Biochim. Biophys. Acta 851, 139-145. 
Tipping, E., Ketterer, B., and Christodoulides, L. (1979) Interactions of small 
molecules with phospholipid bilayers. Biochem. J. 180, 327-337. 
Tsuchida, E. ,(1994) Stabilized hemoglobin vesicles. An. Cell, Blood subs., and 
lmmob. Biotech. 22, 467-477. 
Van Den Berg, J. J. M., Op Den Kamp, J. A. F., Lubin, B. H., Roelofsen, B., and 
Kuypers, F. A. (1992) Kinetics and site specificity of hudroperoxide-induced 
oxidative damage in rd blood cells. Free Rad. Biol. and Med. 12, 487-498. 
Watkins, J. A., Kawanishi, S., and Caughey, W. S. (1985) Autoxidation reactions of 
hemoglobin A free from other red cell components: a minimal mechanism. Biochi7!l. 
Biophys. Res. Comm. 132, 742-748. 
Whitaker, T. L., Berry, M. B., Ho. E. L., Hargrove, M. S., Phillips, G. N., 
Komiyama, N. H., Nagai, K., and Olson, J. S. (1995) The D-helixin myoglobin and 
in the subunit of hemoglobin is required for the retention of heme. Biochemistry 34, 
8221-8226. 
Winterbourn, C. C. (1990a) Oxidative denaturation in congenital hemolytic anemias: 
The unstable hemoglobins. Seminars in HemaJology 21, 41-50. 
Winterbourn, C. C. (1990b) Oxidative reactions of hemoglobin. Methods in 
enzymology 186, 265-272. 
Winterbourn, C. C. (1985a) Hemoglobin Oxidation and inter-relationship with lipid 
92 
peroxidation in the red cell, In cellular and molecular aspects of aging, Eaton, J. 
W., Konzen, D. K., and White, J. G., Eds., Alan R. Liss Inc., New York 173-182. 
Winterboum, C. C. (1985b) Free-radical production and oxidative reactions of 
hemoglobin. Env. Health Perspectives 64, 321-330. 
Winterboum, C. C. (1985c) Reactions of superoxide with hemoglobin, In CRC 
handbook of methods for oxygen radical research. Greenwald, R. A., Ed., CRC 
Press, Boca Raton, Florida 137-141. 
Winterboum, C. C. (1983) Hemoglobin oxidation and free radical production in the 
red cell. Biomed. Biochim. Acta 42, 134-138. 
Yang, E. and Huesstis, W. H. (1994) Oxidative interactions between the erythrocyte 
membrane and phosphotidylcholine vesicles. J. Biol. Chem. 269, 14518-14524. 
VITA 
The author, Merita Nirmalie Dias, was born in Sri Lanka on May 17, 1965. After 
finishing her high school (GCE / AL) she entered to the Institute of Chemistry Ceylon, 
Sri Lanka to persue higher studies. At the same time she worked part-time at the 
University of Peradeniya as a Research Technician on a project funded by the World 
Health Organi7.ation (WHO), and later did her practical training as a part of her 
graduateship program at the same place. Her work involved isolation, purification and 
characteri7.ation of anti-fertility compounds and anti-cancer compounds from higher 
plants. From her research conducted at the University of Peradeniya under the guidance 
of Professor Leslie Gunatilake she co-authored two publication in refereed journals. She 
graduated in 1990 from the Institute of Chemistry Ceylon with the Graduateship in 
Chemistry which is equivalent to a special degree in honors in chemistry. After 
graduating in 1990 she joined Chemical Industries Colombo Ltd., as a member of the 
management staff and was involved in quality control and research and development of 
adhesives, detergents and agro-chemicals. She resigned Chemical Industries Colombo 
Ltd in 1991 to join her husband in Chicago, IL, USA. To persue her higher studies she 
joined University of Illinois at Chicago, Chicago as Visiting Research Specialist at the 
Department of Medicinal Ch~mistry and Pharmacognosy. Her work involved cytotoxicity 
assay and receptor binding assay to identify anticancer compounds. In 1992 she joined 
Loyola University Chicago as a full time graduate student at the Department of 
92 
Chemistry. In 1993 January she started research under the direction of Professor Leslie 
W.-M. Fung. During her Graduate studies she presented posters at the Bio-physical 
Society National Meetings at New Orleans, San francisco, Baltimore, 1993, 1994, and 
1995, respectively. She was among the ten recipients for a dissertation fellowships 
awarded by the University for the 1995-1996 academic year. For the period of 1993-
1995, she was also a teaching assistant in organic chemistry and general chemistry. 
Ms. Dias, married Dr. Mahinda Wickramaratne in 1991 and now a mother of 
an 8 months old daughter Angelle. 
The author's formal publications are listed below: 
1. "Studies on terpenoids and steroids. Part 20. Isolation and NMR analysis of 15,22-
dihydroxytingenone: a probable biosynthetic precursor of 14(15) ene-quinone-methide 
tritrepenoids": M. N. Dias, H. C. Fernando, A. A. L. Gunatilake, Y. Tezuka, T. 
Kikuchi. J. Chem. Res. (S) (1990) 22 238-239, 
2. "Studies on terpenoids and steroids. Part 24, The effect of some natural 
quinonemethide and 14(15)-ene-quinonemethide nortiterpenoids on motility of human 
spermatozoa in vitro": G. S. A. Premakumara, W. D. Ratnasuriya, S. 
Balasubramanium, B. Danabalasingham, H. C~ Fernando, M. N. Dias, N. L. V. V. 
Karunaratne and A. A. L. Gunatilake. Phytochem. (Life. Sci. Adv.) (1992) 11, 219-
223, 
3. "Erythrocyte spectrin maintains its segmental motion on oxidation: A spin label EPR 
study": L. W.-M. Fung, Benito 0. Kalaw, Rita Hatfield and Merita N. Dias. (1996) 
Biophy. Journal. (1996) 70, 841-851. 
93 
APPROVAL SHEET 
The dissertation submitted by Merita Nirmalie Dias has been read and approved by the 
following committee 
Dr. Leslie W.-M Fung, Director 
Professor, Chemistry, Loyola University of Chicago 
Dr. Patrick Henry 
Professor, Chemistry, Loyola University of Chicago 
Dr. Albert J. Rotermund 
Professor, Biology, Loyola University of Chicago 
Dr. Daniel Graham 
Professor, Chemistry, Loyola University of Chicago 
Dr. Richard Kassner 
Professor, Chemistry, University of Illinois at Chicago, Chicago 
The Final copies have been examined by the director of the dissertation and the signature 
which appears below verifies the fact that the necessary changes have been incorporated 
and that the dissertation is now given the final approval by the Committee with reference 
to content and form. 
This Dissertation is therefore accepted in partial fulfillment of the requirement for the 
degree of Doctor of Philosophy. 
94 
